Sanofi outs operating chief Guerin (Sanofi Synthelabo SA's COO Herve Guerin)

Article Abstract:

French pharmaceuticals giant Sanofi-Synthelabo removes Herve Guerin as its chief operating officer, even as the company reports a 58% increase in profit for the first six months this year.

Human resource management, Sanofi-Synthelabo, Corporate officers, Guerin, Herve

---

Sanofi-Synthelabo's Net Jumped 23% In Second Half, Underscoring Strength

Article Abstract:

French pharmaceuticals company Sanofi-Synthelabo S.A., reports 23% increase in profit for the second half of the year. The company plans to concentrate on three of its promising drugs that helped its strong performance.

Strategy & planning, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Finance, Sanofi-Synthelabo SA

---

Novartis names CEO Vasella to be next chairman. (Daniel Vasella succeeds Alex Krauer)

Article Abstract:

Switzerland's pharmaceuticals giant Novartis AG, names its Chief Executive Officer Daniel Vasella as successor to current chairman Alex Krauer who is retiring from the company.

Comment:

Pharmaceuticals giant Novartis AG, names Daniel Vasella to succeed chairman Alex Krauer.

Switzerland, Novartis AG, Vasella, Daniel, Krauer, Alex

Similar abstracts:

• Abstracts: World Online 's founder admits link to five failed companies. World Online plans give-back offer for worker shares
• Abstracts: Asarco signs Phelps Dodge's deal to be acquired for cash and stock. UniCredito to buy Pioneer Group for $1.2 billion
• Abstracts: Brand power: how marketers across Canada used mobile to engage consumers with their brands. Will you still feed me, when I'm 64?
• Abstracts: Invensys issues profit warning, plans to cut thousands of jobs. Racal's pretax profit plummets by 40%
• Abstracts: One dream at a time,Euro Disney is drawing visitors and aiming to win over investors next. Euro Disney net income soars by 64%, despite fewer visitors

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.